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Background: Cardiovascular disease as the first silent killer in the world is re-
lated to atherosclerosis plaque. Coronary artery bypass grafting as a gold stand-
ard for severe atherosclerosis needs alternative materials to replace the nar-
rowed artery due to plaque. PLLA is one of the biodegradable polymers which 
is suitable for the vascular graft, but some of its weaknesses should be ad-
dressed. 
Objective: The aim of this research is to improve PLLA characteristics for a 
vascular graft candidate by using collagen and chitosan. 
Methods: This study was an experimental study that consisted of two steps, 
preparation of hollow fiber and evaluation of its characteristic. This research 
evaluated the effect of chitosan concentration against cytotoxicity and hemo-
compatibility using MTT assay and hemolytic test. 
Results: The result showed that chitosan could improve the biological charac-
teristics of hollow fiber PLLA-collagen, non-toxic, and non-hemolytic. 
Conclusions: There is a good effect on the biological characteristics of PLLA-
Collagen hollow fiber by adding chitosan on the surface of PLLA-Collagen hol-
low fiber. 
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Cardiovascular disease (CVD) is the first silent killer in the 
world. Though it has been declined in the last 25 years, it 
is still the first killer 1,2. It has been predicted that 45% of 
the adult population in the US will suffer CVD in 2035 3. 
CVD is related to coronary atherosclerosis plaque. Ather-
osclerosis is a condition where the blood vessel get narrow 
due to plaque 4. The most common effective treatment for 
severe atherosclerosis is coronary artery bypass grafting 
(CABG) 5. CABG is a gold standard for surgery to replace 
a narrowed artery with new vessels. The new vessels for 
CABG usually come from autologous vessels, such as a 
saphenous vein and internal thoracic artery. Unfortunately, 
the viability of the source is limited. Moreover, it requires 
an invasive harvest, and it is often unsuitable for use 6,7. 
Due to some limitations for autologous vessels, synthetic 
vascular graft is needed as an alternative 6. 
 
The synthetic vascular graft should be made from materi-
als that have good characteristics, such as, hemocompat-
ible, non-toxic, non-thrombogenic, and good mechanical 
characteristics. Polymer is one of the materials that has 
been used for the vascular graft. One kind of polymers 
suitable for the vascular graft is poly L-lactic acid (PLLA). 
PLLA is a common biodegradable polymer for synthetic 
vascular graft 8. The previous research showed that a po-
rous PLLA nanofiber scaffold is very potential for vascular 
graft tissue engineering reconstruction 9. 
 
PLLA has degradation times around 6-12 months 10. It can 
be accepted on the human body due to the presence of 
lactic acid. Unfortunately, PLLA is not able to promote cell 
growth and differentiation. Growth-factor-like substances 
should be added on PLLA to trigger cell adhesion. The pre-
vious study showed that collagen improved the ability of 
PLLA to promote cell growth and differentiation 11.  
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The degradation product of PLLA is able to enter the 
Kreb’s cycle. The degradation process of PLLA occurs due 
to the hydrolytic mechanism. It is started from the diffusion 
process of body fluid to materials and cut the chain off on 
the oligomer 12. This hydrolytic degradation causes the de-
cline of pH, so that is triggering inflammation reaction and 
allergenic 13. Another drawback of PLLA is its hydrophobic 
characteristics which do not lead the cell adhesion. There-
fore, surface modification is needed to improve the biolog-
ical characteristics of PLLA 14. 
 
Chitosan is added on the surface to cover the hydrophobic 
surface of the PLLA. Chitosan will induce cell proliferation 
and minimize the odd body reaction. Chitosan is a natural 
cationic that can act as a buffer to maintain the pH of PLLA 
during the degradation process 15. The structure of chi-
tosan is similar to glycosaminoglycans (GAGs) in mam-
mals which mostly can be found on the cell surface and 
matrix extracellular 16. Chitosan on the surface of materials 
will support cell attachment and proliferation 17,18. Chitosan 
has potential benefits for tissue regeneration due to its bi-
ocompatibility, biodegradability and bio-absorbability. It 
also increases the production of transforming-beta 1 (TGF 
1) and platelet-derived growth factor (PDGF) 19.  
 
The aim of this research is to improve the characteristics 
of PLLA using chitosan and collagen. Collagen is the main 
component of the extracellular matrix that will enhance the 
cell adhesion and also increase elasticity 20. Collagen also 
has a role in promoting the formation of endothelial cell 21. 
Collagen has a good tensile strength that play an important 
role in the component for ligament, tendon, and it is also 
responsible for skin elasticity. The degradation rate of col-
lagen can be controlled using enzymatic pre-treatment or 
crosslinking.  
METHOD 
This study was an experimental study that aimed to assess 
the effect of chitosan addition on the PLLA-collagen hollow 
fiber surface. It consisted of two steps; preparation of hol-
low fiber and biological properties assessment. The bio-
logical assessment of this study that had been evaluated 
was the cytotoxicity and hemocompatibility of materials. 
Cytotoxicity evaluation had been done by using MTT as-
say and hemolytic test for hemocompatibility evaluation. 
The independent variable of this research was chitosan 
concentration, while the dependent variables were living 
cell viability and hemolytic percentage. 
Preparation of Hollow Fiber 
Hollow fiber was made from PLLA (Mw 180kDa) and col-
lagen. 20% PLLA solution was produced by dissolving 
PLLA with chloroform-toluene with a ratio of 5:1. PLLA so-
lution was blended with a 1% collagen solution with a ratio 
of 2:1 using magnetic stirrer at room temperature. It was 
formed into hollow fiber using a spinneret apparatus (fig-
ure 1). Alcohol was used as a coagulant. 
 
Figure 1. Spinneret apparatus scheme 
 
The next process was coating hollow fiber with chitosan. 
Chitosan was dissolved on 1% acetate acid and added 1N 
NaOH until pH reach level 6. There were five chitosan con-
centration used in this research, 0.05%; 0.075%; 0.1%; 
0.125% and 0.15% (wt/v). Hollow fiber was dipped into the 
chitosan solution for 30 minutes. The last process of the 
coated hollow fiber was freeze-dried. There was one 
PLLA-collagen hollow fiber without chitosan coating as a 
control. 
Cytotoxicity Test 
The cytotoxicity test is a mandatory test for biomaterials. 
MTT assay was used in this study to assess the cytotoxi-
city characteristics of the hollow fiber. The confluent BHK-
21 cell culture from the cell line was harvested by using a 
0.25% trypsin versene solution. Afterward, those cells 
were moved to a 96-microwell plate. The sterilized sam-
ples were put into well plates. Those well plates were in-
cubated for 4 hours with the temperature at 37oC. The next 
step was removing samples from the well plates and add 
50μL on each well. In the end, the optical density of form-
azan crystals on a96-microwell plate was monitored by 
ELISA reader with 630λ 22. The living cells percentage can 










                
  (1) 
Hemolytic Test 
The hemolytic test is a mandatory test for biomaterials that 
have contact with blood. This test was using anticoagu-
lated human blood. 200μL blood was diluted on 10mL of 
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0.9% saline as a negative control, and 200μL blood was 
diluted on 10mL aquades as a positive control. Samples 
were put into microtube with 200μL of blood-saline and in-
cubated for 2 hours on the water bath with the temperature 
at 37oC. Afterward, samples were removed, and the blood 
was centrifuged with 3000 rpm for 10 minutes. The super-
natant was taken from microtube to assess the absorb-
ance using UV-Vis spectrophotometry with 490nm of 
wavelength. This absorbance can be used to calculate the 
hemolytic percentage by using following equation23: 
%𝐻𝑒𝑚𝑜𝑙𝑦𝑡𝑖𝑐 =  
𝐴𝑠𝑎𝑚𝑝𝑙𝑒−𝐴𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒 𝑐𝑜𝑛𝑡𝑟𝑜𝑙
𝐴𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑐𝑜𝑛𝑡𝑟𝑜𝑙
× 100%                 
  (2) 
RESULTS  
Hollow fiber was successfully formed by the mixture of 
PLLA-Collagen using the spinneret apparatus (figure 2.a). 
This hollow fiber has a smooth white surface with a diam-
eter of around 2.225-2.955 mm. The thickness of the vas-
cular graft was also measured using the scanning electron 
microscope (SEM). The result showed that the thickness 
was between 90.65 – 236.26μm (figure 2.b). 
 
Cytotoxicity of the vascular graft with different concentra-
tions of chitosan coating was evaluated on the BHK-21 cell 
culture. The optical density (OD) of formazan crystal and 
cell viability can be seen in table 1. The percentage of the 
living cell for all groups was more than 50%. 
 
The hemolytic test showed that hemolytic percentage from 
all groups was under 5%. It meant that all of the vascular 
graft was safe to have contact with blood 24. The highest 
hemolytic percentage was sample 1, and the lowest was 
sample 5. The percentage of hemolytic was getting smaller 
along with the increase of chitosan concentration.  
DISCUSSION 
This research had successfully produced the PLLA-colla-
gen hollow fiber using a spinneret apparatus. This hollow 
fiber was coated with chitosan in order to improve the bio-
logical characteristics, cytotoxicity, and hemocompatibility. 
The physical of hollow fiber was observed using SEM. 
From the observation, it can be seen that hollow fiber has 
a diameter of around 2.225-2.955mm. Based on the diam-
eters, this vascular graft is suitable for artery coronary ap-
plication as artery coronary has a diameter of around 2.1-
6.5mm 25. The pore sizes of hollow fiber also vary between 
4.525-18.06μm. The porosity on hollow fiber is affected by 
the composition of the solution, hydrogen bond, and tem-
perature26.  The increase of chitosan concentration would 
fill the macro-porous on PLLA with low density. Pore size 
has a pivotal role in the vascular graft. It is able to affect 
cell adhesion, which is as a key role in vascularization27. 
The best size of pore on vascular graft is 5-45μm. By this 
size, the endothelial cell could grow better28.
 
Table 1. The result of cytotoxicity test 
Group Optical Density Value Cell Viability (%) 
Control 0.383+0.027 96.03% 
Sample 1 0.344+0.025 88.10% 
Sample 2 0.361+0.047 91.56% 
Sample 3 0.387+0.012 96.85% 
Sample 4 0.342+0.037 87.69% 
Sample 5 0.329+0.042 85.05% 
 
Table 2. The result of hemolytic test 
Group Absorbance Average  Hemolytic Percentage (%) 
Control 0.0503+0.004  4.24% 
Sample 1 0.0453+0.003  3.29% 
Sample 2 0.0447+0.002  3.15% 
Sample 3 0.0420+0.001  2.61% 
Sample 4 0.0413+0.002  2.45% 
Sample 5 0.0380+0.001  1.57% 
Control : PLLA-collagen hollow fiber without chitosan coating 
Sample 1 : PLLA-collagen hollow fiber with 0.05% (wt/v) chitosan 
Sample 2 : PLLA-collagen hollow fiber with 0.075% (wt/v) chitosan 
Sample 4 : PLLA-collagen hollow fiber with 
0.125% (wt/v) chitosan 
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Sample 3 : PLLA-collagen hollow fiber with 0.1% (wt/v) chitosan Sample 5 : PLLA-collagen hollow fiber with 




Figure 2. Hollow fiber PLLA-Collagen (a), Cross section of hollow fiber PLLA-Collagen from Scanning 
Electron Microscope (SEM) with 80 magnitude (b). 
 
The cytotoxicity assay showed that the percentage of a liv-
ing cell from all samples was above 50%. It meant that the 
vascular graft from all groups is non-toxic. High optical 
density value indicates high cell viability in the case of MTT 
Assay. This OD shows the concentration of formazan crys-
tal. Living cells absorbed MTT and broke it down through 
reduction reaction using reductase enzyme on mitochon-
dria respiration chain29. The addition of chitosan did not 
affect the PLLA cytotoxicity. 
 
Hemocompatibility is one of the crucial characteristics of 
blood contacted materials. In this research, hemocompat-
ibility properties were measured using the hemolytic test. 
Hemolytic is a condition where erythrocytes were dam-
aged due to the disruption of membrane cell integrity. The 
principle of the hemolytic test measures the hemoglobin 
level due to the destruction of red blood cells when contact 
with foreign materials30. Based on the hemolytic test result, 
all of the samples have good hemocompatibility. The he-
molytic percentage showed the amount of hemoglobin due 
to the rupturing of erythrocyte since its contact with foreign 
materials. Based on ASTM F756-00, materials that are 
safe to contact with blood should have hemolytic percent-
ages under 5% 24. 
 
The increase of chitosan concentration gave a positive im-
pact on PLLA-collagen hollow fiber. The increase in chi-
tosan concentration decreased the hemolytic percentage. 
It showed that the increase in chitosan concentration could 
cover the PLLA-collagen surface. Chitosan made the sur-
face of hollow fiber smoother. Therefore, it decreased the 
friction between the hollow fiber surface and the blood 
component. In the case of a vascular graft, the roughness 
of surface could trigger blood flow turbulence and initiate 
the hemolytic process 31. 
CONCLUSIONS AND RECOMMENDATION 
The surface modification of PLLA-collagen using chitosan 
successfully improved its biological characteristics, espe-
cially on hemocompatibility. The increase in chitosan con-
centration could minimize the hemolytic process. It could 
be concluded that chitosan was able to enhance the he-
mocompatibility of the materials, which is pivotal for vas-
cular graft candidates. Further research is still needed to 
evaluate the effect of chitosan concentration on the endo-
thelialization process. 
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